Lung carcinoma with lung tissue microarray, 4 cores per case, divided into two identical 12 core arrays for testing different antibody dilutions. Pathology grade, TNM Classification, and Clinical Stages information available. Replacing T041.
- 1 case of adenocarcinoma and small cell carcinoma
- 2 cases of squamous cell carcinoma
- 2 cases of normal lung tissue
Catalogue No |
T041a |
Species |
Human |
Fixative |
Formalin |
Total Cases |
6 |
Total Cores |
24 |
Core Diameter |
1.5 mm |
Section Thickness |
5 µm |
Storage |
Short term RT; Long term 4ºC |
Usage |
For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|
1 | A1 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
2 | A2 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
3 | A3 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
4 | A4 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
5 | A5 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
6 | A6 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
7 | A7 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
8 | A8 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
9 | B1 | 50 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
10 | B2 | 50 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
11 | B3 | 51 | F | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
12 | B4 | 51 | F | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
13 | B5 | 50 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
14 | B6 | 50 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
15 | B7 | 51 | F | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
16 | B8 | 51 | F | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
17 | C1 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
18 | C2 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
19 | C3 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
20 | C4 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
21 | C5 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
22 | C6 | 47 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
23 | C7 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
24 | C8 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |